Data Science. Stocks. Tennis.
Kailua, HI
Joined July 2020
- Tweets 1,502
- Following 355
- Followers 200
- Likes 4,649
crheat retweeted
$IONQ $22B
$QBTS $9.5B
$RGTI $10B
$QUBT $3.5B
All for the potential for a total of $4B market after 2030.
Keep in mind they are not at all talking about the names above. This is about $IBM, $GOOG, $NVDA and alike.
crheat retweeted
This $IONQ CEO is worse than Trevor Milton, essentially calling $NVDA GPUs obsolete for supercomputers by 2027. Quantum computing is only useful for certain calculations involving large number sets/encryption/etc.
VERY SMALL USE CASE
Bro has the confidence of a Roman Legatus Augusti pro praetore, without any army or anything to back it up...
crheat retweeted
IONQ
@SECGov
@SECPaulSAtkins
$IONQ caught in 4K - "Cisco has a market cap of hundreds of billions of dollars. At minimum, the future of IonQ looks like that and the ceiling of it looks like Nvidia."
This is the craziest statement from a CEO I have ever heard and I went to prison for securities fraud.
Here is $IONQ CEO Nicolo De Masi making forward looking statements about the valuation of $IONQ. Stating that the valuation should be at least that of $CSCO ($200bn) and hence implying a high return for existing investors. $IONQ is followed by a large portion of retail investors, which Nicolo seems be targeting given that this discussion was held on this platform during a live event held by @StockMeetUps on June 10th 2025. The original stream has now been deleted.
cc: @SECGov, In my opinion, it is worth checking holistically whether Nicolo and $IONQ are making misleading statements and lack cautionary language in their forward looking statements, while continuously selling their shares to the public. Especially given the strong following from retail investors.
cc: @MartinShkreli, whose livestream on June 12th 2025 helped me find the audio.
$IBRX Wouldn’t Waldenstrom be an example of a rare cancer that qualifies for accelerated approval under the @DrMakaryFDA new RDEP program? @DrPatSoonShiong
crheat retweeted
RIP Charlie Kirk.
Renowned surgeon & scientist Dr. Patrick Soon-Shiong delivered a chilling warning to Charlie Kirk and his audience: The world was facing a global pandemic of "turbo cancers" in young people.
The anecdotal evidence had become a terrifying medical reality. Cancer rates were not just up—they were skyrocketing in a demographic that was once considered low-risk.
Dr. Soon-Shiong stated he was seeing cases he once thought impossible:
▪️ 10-year-olds with colon cancer.
▪️ 13-year-olds with metastatic pancreatic cancer.
▪️ 21-year-olds with ovarian cancer.
He attributed this crisis to a catastrophic failure of the human immune system, driven by a "combination of all" modern toxins:
▪️ Environmental Poisons: PFAS "forever chemicals" found in milk and even organic foods, and used in fertilizers.
▪️ Electromagnetic Radiation: He cited higher cancer rates in military pilots, pointing to a potential link from constant EMF exposure.
▪️ The COVID Effect: Whether from the virus itself or the vaccine, persistent COVID infection was described as "highly immunosuppressive." This immune depletion, layered on top of existing environmental toxins, was creating a perfect storm for aggressive cancers.
This was not just an American phenomenon. Dr. Soon-Shiong confirmed it was a global crisis, with rising cases from the United States and Canada to Africa and the Middle East.
The promise of modernity was broken. We were supposed to get healthier. Instead, a generation was getting sicker with cancers that were once considered rare.
$IBRX According to MD Anderson study, about 80% of stage 3 NSCLC cancer patients receiving chemoradiotherapy develop grade 3 or worse Lymphopenia (ALC<500). Urgent unmet need for Ankvita treatment.
frontiersin.org/journals/onc…
Exciting results in lung cancer today.
It is my belief that treating lymphopenia in patients with low NK and T cell count, is as essential as treating anemia (low red blood cells count) or neutropenia (low neutrophil count) which occurs as a consequence of chemotherapy, independent of tumor types.
This will herald in the paradigm change of treating the immune system itself and allow the immune system to cure the cancer, regardless of its anatomical location.
The long-term survival in patients with bladder cancer and now in lung cancer provide evidence of the potential validity of this hypothesis, with ANKTVIA as the foundation of the Bioshield platform.
businesswire.com/news/home/2…
crheat retweeted
$IBRX if you are a cancer patient or suffering from LongCovid you should read this and ask questions>
@US_FDA @DrMakaryFDA because, it is your life at stake!
Dr. P.S.S: “Next week we will share our data in 86 patients with lung cancer who failed chemo and some who failed both chemo and radiation…..But why are we waiting to catch patients once they already in a deep hole? Why not protect their cells from the outset?” @VPrasadMDMPH
@POTUS @SecKennedy @NIHDirector_Jay
Next week we will share our data in 86 patients with lung cancer who failed chemo and some who failed both chemo and radiation and all 86 who progressed on checkpoints. Our study involved accepting these 2nd and 3rd line patients and WHILE THEY WERE STILL PROGRESSING on the checkpoint, to add the Bioshield and then measure for overall survival with the same checkpoint plus Bioshield.
The test was: did lymphocytes ( NK cells and T cells) matter and could these patients be rescued after 2nd and 3rd line therapy even after destruction of their immune system by current standards of care.
Data coming: NK cells matter!!
But why are we waiting to catch patients once they already in a deep hole? Why not protect their cells from the outset?
$IBRX Proven ability of Anktiva and Bioshield platform to treat Lymphopenia and restore healthy ALC levels with increased survival!
@DrMakaryFDA
@SecKennedy
“But why are we waiting to catch patients once they already in a deep hole? Why not protect their cells from the outset?”
Next week we will share our data in 86 patients with lung cancer who failed chemo and some who failed both chemo and radiation and all 86 who progressed on checkpoints. Our study involved accepting these 2nd and 3rd line patients and WHILE THEY WERE STILL PROGRESSING on the checkpoint, to add the Bioshield and then measure for overall survival with the same checkpoint plus Bioshield.
The test was: did lymphocytes ( NK cells and T cells) matter and could these patients be rescued after 2nd and 3rd line therapy even after destruction of their immune system by current standards of care.
Data coming: NK cells matter!!
But why are we waiting to catch patients once they already in a deep hole? Why not protect their cells from the outset?
$IBRX 100% disease control and 2 near complete responses so far. Early results but this may develop into a 100% complete response rate. But these are already unprecedented results that surpass clinical benefits seen in a similar Optune/Keytruda trial. Anktiva + CAR NK=blockbuster
crheat retweeted
Why isn’t @SecKennedy @RobertKennedyJr getting this approved for front line therapy? His uncle Ted died of Glioblastoma right? The “Right to Try” act of 2018 under the @realDonaldTrump administration needs to be amended for front line therapy, not after you’ve barbarically already burned, radiated, and destroyed your immune system. The whole premise of medicine is to “do no harm.” WTF is chemo and radiation? What could be better than jump starting our own God-given immune system to fight this disease and many others that all of us have lost love ones too or fighting ourselves. Where is the #FDA on this? Thousands are dying every day! Children are dying! Influential people such as @elonmusk complain about low birth rates and warn us that society will collapse, but we have treatments that keep people alive or cure them and it’s crickets at the FDA, NIH, & CDC. What’s wrong? Worried you’ll offend big pharma? Have some integrity and grow a pair like the courageous souls fighting for their lives at this very moment! @DrMakaryFDA, @CDCMonarez, @NIHDirector_Jay, @DrOzCMS where are you? Hello McFly? For the love of God, wake up and go down in history as a hero, not a sheep. Please, everyone that reads this, share with everyone you know. Pass it on to media and podcast personalities like @joerogan @megynkelly @TuckerCarlson @ShawnRyan762 @Timcast and anyone you can think of that doesn’t kneel to big pharma like main stream media.
$IBRX Longevity without health isn’t of any value. @ImmunityBio cancer bioshield platform gives patients the opportunity to return to health. Multiple examples of complete responses achieved without the need for debilitating chemotherapy treatments. @SecKennedy @DrMakaryFDA
$IBRX Another example of the type of chemotherapy free, late stage cancer immunotherapy treatment resulting in a complete response for ImmunityBio. This time in Non-Hodgkins Lymphoma. As David pointed out this is just the type of treatment that FDA head Marty Makary touted.
$IBRX
It's exceptionally uncommon for the FDA head to overtly champion a drug from a biotech company personally. But this just happened, in my view.
Here’s the story:
Three weeks ago, Dr. Haggi appeared on "Cancer Decoded" with @MarkHalperin and
@DrPatSoonShiong
He discussed the results that Anktiva—the wonder drug from ImmunityBio—had on a patient of his with brain cancer. He referred to MRIs from this patient and said that the cancer just melted away.
Then, just three days ago, there’s this interview with
@DrMakaryFDA , the new head of the FDA, saying he wants to approve new cancer drugs that can literally melt away cancer - WITHOUT CHEMO OR RADIATION.
I DO NOT BELIEVE THIS IS A COINCIDENCE.
From these two videos I think the FDA is closely looking at how they can grant broader approval for Anktiva to more cancer patients.
To me as a financial analyst, this signals strong potential support for the shares of ImmunityBio. If official good news comes from the FDA—such as expanded approvals for Anktiva—the stock could move much higher.
#MAHA
crheat retweeted
History repeats itself - another one of D-WAVE’s “quantum advantages” disproven in short order. As I’ve been saying, they’ve been running the same scam since 1999. $QBTS
1/
$QBTS
🚨Huge news🚨
The USC paper claiming "Scaling Advantage in Approximate Optimization" has been DEBUNKED just one month after its publication.
arxiv.org/pdf/2505.22514
In this thread, I'll dissect some details of the story and important implications about D-Wave's behavior.
$ENVX The upcoming Vivo Y300 pro+ looks like a strong candidate for first mobile phone model to use @EnovixBatteries
91mobiles.com/hub/vivo-y300-…
$ENVX - parameters are limited for the smartphone release in Q4 2025. Have a look yourself. There are not many options given the PR details and OEM releases. The question is as a ranked list what are the current best options and how does this change over the next 2 months. . .
crheat retweeted
.@EnovixBatteries CEO Raj Talluri joins @JillMalandrino on @Nasdaq #TradeTalks from @CES X @CTATech to discuss powering the technologies of the future with disruptive battery architecture. #CES2025 x.com/i/broadcasts/1zqJVYPNM…